UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Topiramate and Phenytoin Pharmacokinetics During Repetitive Monotherapy and Combination Therapy to Epileptic Patients

Epilepsia (Copenhagen), 2002-07, Vol.43 (7), p.691-696

2002

Volltextzugriff (PDF)

Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: In vitro and in vivo comparison and calculation of in vivo inhibition constants

Clinical pharmacology and therapeutics, 1997-11, Vol.62 (5), p.490-504

1997

Volltextzugriff (PDF)

Mechanisms of the stereoselective interaction between miconazole and racemic warfarin in human subjects

Clinical pharmacology and therapeutics, 1992-06, Vol.51 (6), p.656-667

1992

Volltextzugriff (PDF)

Lack of Effect of Azelastine and Ketoconazole Coadministration on Electrocardiographic Parameters in Healthy Volunteers

Journal of clinical pharmacology, 1997-11, Vol.37 (11), p.1065-1072

1997

Volltextzugriff (PDF)

The mechanism of the warfarin-rifampin drug interaction in humans

Clinical pharmacology and therapeutics, 1987-10, Vol.42 (4), p.388-394

1987

Volltextzugriff (PDF)

Racemates versus enantiomers in drug development: Dogmatism or pragmatism?

Chirality (New York, N.Y.), 1990, Vol.2 (3), p.129-133

1990

Volltextzugriff (PDF)

Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans

Clinical pharmacology and therapeutics, 1987-09, Vol.42 (3), p.290-294

1987

Volltextzugriff (PDF)

The warfarin-sulfinpyrazone interaction: stereochemical considerations

Clinical pharmacology and therapeutics, 1986-01, Vol.39 (1), p.15-24

1986

Volltextzugriff (PDF)

Metabolic enantiomeric interactions: The inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin

Chirality (New York, N.Y.), 1991, Vol.3 (1), p.24-29

1991

Volltextzugriff (PDF)

The mechanism of the interaction between amiodarone and warfarin in humans

Clinical pharmacology and therapeutics, 1992-04, Vol.51 (4), p.398-407

1992

Volltextzugriff (PDF)

High-Yield Synthesis of Warfarin and Its Phenolic Metabolites: New Compounds

Journal of pharmaceutical sciences, 1983-07, Vol.72 (7), p.830-831

1983

Volltextzugriff (PDF)

Pharmacokinetic Implications of Stereoselective Changes in Plasma–Protein Binding: Warfarin/Sulfinpyrazone

Journal of pharmaceutical sciences, 1984-11, Vol.73 (11), p.1671-1673

1984

Volltextzugriff (PDF)

Metabolic Fate of Phenprocoumon in Humans

Journal of pharmaceutical sciences, 1985-10, Vol.74 (10), p.1037-1040

1985

Volltextzugriff (PDF)

A stable isotope assay for phenprocoumon and its metabolites

Biological Mass Spectrometry, 1985-02, Vol.12 (2), p.67-71

1985

Volltextzugriff (PDF)

The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans

Clinical pharmacology and therapeutics, 1987-09, Vol.42 (3), p.312-319

1987

Volltextzugriff (PDF)

Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by ( )-warfarin is not enhanced in cystic fibrosis

Clinical pharmacology and therapeutics, 1993-09, Vol.54 (3), p.323-328

1993

Volltextzugriff (PDF)

A sensitive and specific stable isotope assay for warfarin and its metabolites

Biological Mass Spectrometry, 1983-07, Vol.10 (7), p.395-398

1983

Volltextzugriff (PDF)

Quantification of Lidocaine and Several Metabolites Utilizing Chemical-Ionization Mass Spectrometry and Stable Isotope Labeling

Journal of pharmaceutical sciences, 1977-08, Vol.66 (8), p.1180-1190

1977

Volltextzugriff (PDF)

The crystal and molecular structure and absolute configuration of (−)-(S)-warfarin

Acta Crystallographica Section B, 1975-04, Vol.31 (4), p.954-960

1975

Volltextzugriff (PDF)

Biotransformation and Excretion: Quantitative Studies

Journal of clinical pharmacology, 1986-07, Vol.26 (6), p.443-447

Trager, William F.

1986

Volltextzugriff (PDF)

Fluvoxamine–theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2

Clinical pharmacology and therapeutics, 2001-11, Vol.70 (5), p.415-424

Yao, C

2001

Volltextzugriff (PDF)

The use of Brauman's least squares approach for the quantification of deuterated chlorophenols

Biological Mass Spectrometry, 1990-04, Vol.19 (4), p.211-217

1990

Volltextzugriff (PDF)

Chemical synthesis, absolute configuration, and stereochemistry of formation of 10-hydroxywarfarin: A major oxidative metabolite of (+)-(r)-warfarin from hepatic microsomal preparations

Chirality (New York, N.Y.), 1990, Vol.2 (2), p.96-105

1990

Volltextzugriff (PDF)

The rapid identification of a new metabolite of warfarin via a chemical ionization mass spectrometry ion doublet technique

Biological Mass Spectrometry, 1975-02, Vol.2 (1), p.23-30

1975

Volltextzugriff (PDF)

Fluvoxamine-theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2

Clinical pharmacology and therapeutics, 2001-11, Vol.70 (5), p.415-424

2001

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

KollektionWiley-Blackwell Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(27)
Pharmacology & Pharmacy
(24)
Humans
(23)
Male
(18)
Biological And Medical Sciences
(17)
Chemistry
(17)
Physical Sciences
(17)
Stereoisomerism
(17)
Medical Sciences
(16)
Pharmacology. Drug Treatments
(16)
Adult
(13)
Chemistry, Medicinal
(13)
Warfarin - Metabolism
(11)
Kinetics
(10)
Chemistry, Multidisciplinary
(9)
Blood. Blood Coagulation. Reticuloendothelial System
(8)
Drug Interactions
(8)
Spectroscopy
(8)
Animals
(7)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

4 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Topiramate and Phenytoin Pharmacokinetics During Repetitive Monotherapy and Combination Therapy to Epileptic Patients

Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: In vitro and in vivo comparison and calculation of in vivo inhibition constants

Mechanisms of the stereoselective interaction between miconazole and racemic warfarin in human subjects

Lack of Effect of Azelastine and Ketoconazole Coadministration on Electrocardiographic Parameters in Healthy Volunteers

The mechanism of the warfarin-rifampin drug interaction in humans

Racemates versus enantiomers in drug development: Dogmatism or pragmatism?

Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans

The warfarin-sulfinpyrazone interaction: stereochemical considerations

Metabolic enantiomeric interactions: The inhibition of human (S)-warfarin-7-hydroxylase by (R)-warfarin

The mechanism of the interaction between amiodarone and warfarin in humans

High-Yield Synthesis of Warfarin and Its Phenolic Metabolites: New Compounds

Pharmacokinetic Implications of Stereoselective Changes in Plasma–Protein Binding: Warfarin/Sulfinpyrazone

Metabolic Fate of Phenprocoumon in Humans

A stable isotope assay for phenprocoumon and its metabolites

The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans

Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by ( )-warfarin is not enhanced in cystic fibrosis

A sensitive and specific stable isotope assay for warfarin and its metabolites

Quantification of Lidocaine and Several Metabolites Utilizing Chemical-Ionization Mass Spectrometry and Stable Isotope Labeling

The crystal and molecular structure and absolute configuration of (−)-(S)-warfarin

Biotransformation and Excretion: Quantitative Studies

Fluvoxamine–theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2

The use of Brauman's least squares approach for the quantification of deuterated chlorophenols

Chemical synthesis, absolute configuration, and stereochemistry of formation of 10-hydroxywarfarin: A major oxidative metabolite of (+)-(r)-warfarin from hepatic microsomal preparations

The rapid identification of a new metabolite of warfarin via a chemical ionization mass spectrometry ion doublet technique

Fluvoxamine-theophylline interaction: Gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2

Aktive Filter

Suchergebnisse filtern